A Prospective Randomised Control Trial to Study the Effectiveness of a Health Service Innovation Using a Modified Virtual Ward Model to Prevent Unscheduled Readmission of High Risk Patients
Primary Purpose
Chronic Diseases
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Intervention
Sponsored by
About this trial
This is an interventional health services research trial for Chronic Diseases focused on measuring readmission, chronic diseases
Eligibility Criteria
Inclusion Criteria:
- Patients with 2 or more unscheduled admission in the last 90 days to selected medical departments
- LACE score of ≥10.
Exclusion Criteria:
- Non-residents
- No telephone contact or a resident address
- Residing in long term care facilities.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Active Comparator
Arm Label
Control
Intervention
Arm Description
Patients in the control group received usual care by the hospital. There was no contact between the patients in the control group and the study team throughout the 3 months interval. A scheduled telephone call was made at the end of 3 months when they were invited to participate in a telephone survey.
Intervention
Outcomes
Primary Outcome Measures
Rate of readmission
Any hospital admission after randomisation
Secondary Outcome Measures
Full Information
NCT ID
NCT02325752
First Posted
December 21, 2014
Last Updated
February 9, 2017
Sponsor
Singapore General Hospital
Collaborators
Agency for Integrated Care, Singapore, Duke-NUS Graduate Medical School
1. Study Identification
Unique Protocol Identification Number
NCT02325752
Brief Title
A Prospective Randomised Control Trial to Study the Effectiveness of a Health Service Innovation Using a Modified Virtual Ward Model to Prevent Unscheduled Readmission of High Risk Patients
Official Title
A Prospective Randomised Control Trial to Study the Effectiveness of a Health Service Innovation Using a Modified Virtual Ward Model to Prevent Unscheduled Readmission of High Risk Patients
Study Type
Interventional
2. Study Status
Record Verification Date
February 2017
Overall Recruitment Status
Completed
Study Start Date
August 2011 (undefined)
Primary Completion Date
October 2012 (Actual)
Study Completion Date
January 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Singapore General Hospital
Collaborators
Agency for Integrated Care, Singapore, Duke-NUS Graduate Medical School
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators conducted an open randomized control study of patients who received the transitional care program versus patients who received usual care at the Singapore General Hospital from Aug 2011 to Sept 2012.
Detailed Description
The investigators conducted an open randomized control study of patients who received the transitional care program versus patients who received usual care at the Singapore General Hospital from Aug 2011 to Sept 2012.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Diseases
Keywords
readmission, chronic diseases
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
840 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
No Intervention
Arm Description
Patients in the control group received usual care by the hospital. There was no contact between the patients in the control group and the study team throughout the 3 months interval. A scheduled telephone call was made at the end of 3 months when they were invited to participate in a telephone survey.
Arm Title
Intervention
Arm Type
Active Comparator
Arm Description
Intervention
Intervention Type
Other
Intervention Name(s)
Intervention
Intervention Description
A multidisciplinary team delivered the transitional care program.
Our transitional care program focused on four key areas:
Post discharge surveillance of the patient to ensure adherence to care plans.
Coordination of follow-up visits with specialist care providers.
Patent education and care giver training.
Activation of community and social services.
Upon recruitment, the patients were interviewed and assessed by the team nurse prior to their discharge. Intervention starts upon discharge from the hospital. The duration of the intervention program was 3 months. A follow-up by telephone was made within 72 hours after discharge to assess patient's condition and adherence to treatment plan. Home visits were made within 2 weeks after discharge.
Primary Outcome Measure Information:
Title
Rate of readmission
Description
Any hospital admission after randomisation
Time Frame
30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Patients with 2 or more unscheduled admission in the last 90 days to selected medical departments
LACE score of ≥10.
Exclusion Criteria:
Non-residents
No telephone contact or a resident address
Residing in long term care facilities.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kheng Hock Lee, MBBS
Organizational Affiliation
Singhealth Foundation
Official's Role
Principal Investigator
12. IPD Sharing Statement
Citations:
PubMed Identifier
27118956
Citation
Lee KH, Low LL, Allen J, Barbier S, Ng LB, Ng MJ, Tay WY, Tan SY. Transitional care for the highest risk patients: findings of a randomised control study. Int J Integr Care. 2015 Oct 22;15:e039. doi: 10.5334/ijic.2003. eCollection 2015 Oct-Dec.
Results Reference
derived
Learn more about this trial
A Prospective Randomised Control Trial to Study the Effectiveness of a Health Service Innovation Using a Modified Virtual Ward Model to Prevent Unscheduled Readmission of High Risk Patients
We'll reach out to this number within 24 hrs